Achieving Value in Cancer Care-the Case of Low- and Middle-Income CountriesByAjay Aggarwal, MD,Richard Sullivan, MD, PhDAugust 21st 2014Commentary
The Global Perspective on Value in Cancer CareByBased on presentations by Elisabeth De Vries, MD, PhD,Richard Sullivan, MD, PhD,Lowell E. Schnipper, MDAugust 21st 2014
Overdiagnosis and Overtreatment: The Cancer ParadigmByBased on presentations by Barbara L. Smith, MD, PhD,Rina S. Punglia, MD, MPH,Laura Esserman, MD, MBA,August 21st 2014
Impact of the Affordable Care Act on Cancer CareByBased on presentations by Rena M. Conti, PhD,Lawrence N. Shulman, MD,Blase N. Polite, MD, MPPAugust 21st 2014
The Oncologist Defines Value of CareByBased on presentations by Reshma Jagsi, MD, DPhil,Daniel P. Sulmasy, MD, PhD,Beverly Moy, MD, MPHAugust 21st 2014
The EGF Receptor (EGFR) Continues to Be a Promising Target in NSCLCByBased on presentations by Pasi A. Janne, MD, PhD,Lecia V. Sequist, MD, MPH,Gideon Michael Blumenthal, MD,Lawrence H. Schwartz, MDAugust 20th 2014
